Ghost Tree Capital

Latest statistics and disclosures from Ghost Tree Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Ghost Tree Capital

Companies in the Ghost Tree Capital portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) 7.0 $31M NEW 100k 313.74
Syndax Pharmaceuticals (SNDX) 6.7 $30M +217% 1.4M 22.24
Trillium Therapeutics Com New (TRIL) 6.4 $29M 2.0M 14.71
Rocket Pharmaceuticals (RCKT) 6.1 $27M +25% 500k 54.84
Iovance Biotherapeutics (IOVA) 5.2 $23M -13% 500k 46.40
Mirati Therapeutics (MRTX) 4.9 $22M +66% 100k 219.64
Apellis Pharmaceuticals (APLS) 4.1 $19M NEW 325k 57.20
Constellation Pharmceticls I (CNST) 4.0 $18M -13% 625k 28.80
Ascendis Pharma A/s Sponsored Adr (ASND) 3.9 $18M -19% 105k 166.78
Arvinas Ord (ARVN) 3.9 $17M +2% 205k 84.93
Mersana Therapeutics (MRSN) 3.6 $16M -42% 600k 26.61
Fate Therapeutics (FATE) 3.3 $15M -17% 165k 90.93
Immunovant (IMVT) 3.1 $14M -42% 300k 46.19
Amicus Therapeutics (FOLD) 3.1 $14M 600k 23.09

Setup an alert

Ghost Tree Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Tg Therapeutics (TGTX) 2.9 $13M +25% 250k 52.02
Travere Therapeutics 2.9 $13M NEW 475k 27.25
Cogent Biosciences 2.8 $12M NEW 1.1M 11.23
Xenon Pharmaceuticals (XENE) 2.4 $11M +115% 700k 15.38
Kura Oncology (KURA) 2.4 $11M +44% 325k 32.66
Iveric Bio (ISEE) 2.1 $9.5M +37% 1.4M 6.91
Surface Oncology (SURF) 2.1 $9.2M 1.0M 9.24
Five Prime Therapeutics (FPRX) 1.9 $8.5M NEW 500k 17.01
Sarepta Therapeutics (SRPT) 1.5 $6.8M -38% 40k 170.50
BioCryst Pharmaceuticals (BCRX) 1.5 $6.7M -53% 900k 7.45
Helix Acquisition Corp Com Cl A 1.3 $5.7M NEW 500k 11.37
Verona Pharma Sponsored Ads (VRNA) 1.3 $5.7M 810k 7.00
Vistagen Therapeutics Com New (VTGN) 1.1 $4.7M NEW 2.4M 1.94
Aldeyra Therapeutics (ALDX) 1.0 $4.5M -48% 650k 6.86
Aclaris Therapeutics (ACRS) 0.9 $4.2M NEW 650k 6.47
Immunic (IMUX) 0.9 $4.1M 265k 15.29
Kalvista Pharmaceuticals (KALV) 0.8 $3.8M -42% 200k 18.99
Moderna Put Option (MRNA) 0.8 $3.7M +250% 35k 104.46
Curis Com New (CRIS) 0.8 $3.5M NEW 425k 8.19
Sierra Oncology Com New (SRRA) 0.7 $3.2M NEW 200k 16.03
Cti Biopharma (CTIC) 0.5 $2.4M NEW 750k 3.22
Millendo Therapeutics (MLND) 0.4 $2.0M 925k 2.14
Amarin Corp Spons Adr New (AMRN) 0.4 $2.0M +300% 400k 4.89
Aptevo Therapeutics Com New (APVO) 0.4 $1.8M NEW 50k 36.66
Wave Life Sciences SHS (WVE) 0.4 $1.6M -52% 200k 7.87
Otonomy (OTIC) 0.3 $1.3M NEW 200k 6.47
Satsuma Pharmaceuticals Ord (STSA) 0.2 $922k 200k 4.61
Biogen Idec (BIIB) 0.1 $539k -47% 2.2k 245.00

Past Filings by Ghost Tree Capital

SEC 13F filings are viewable for Ghost Tree Capital going back to 2013

View all past filings